Home » Topics » Regulatory

Regulatory
RSS

FDA approves Orenitram for PAH

Dec. 24, 2013

FDA approves Sovaldi for chronic hepatitis C

Dec. 9, 2013

FDA approves Xiaflex for Peyronie's disease

Dec. 9, 2013

Daiichi Sankyo launches new formulation of natural tetrahydrobiopterin agent

Dec. 2, 2013

FDA approves Varithena for the treatment of patients with incompetent veins

Nov. 28, 2013

FDA approves Velphoro to treat hyperphosphatemia in patients with CKD on dialysis

Nov. 28, 2013

FDA approves Nexavar for thyroid cancer

Nov. 25, 2013

Onoact 50 approved in Japan for new indication

Nov. 22, 2013

European approval of Kineret for CAPS

Nov. 21, 2013

European Commission approves Prilocaine Lidocaine Plethora for premature ejaculation

Nov. 19, 2013

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...